For the sake of the World, and a Future where Covid -will be with us forever, this wonder drug would be a Godsend.
The only part I am concerned about -- is Most deaths seem to be a result of patients with Comorbities ( Diabiities, Hypertension, Cerebrovascular Disease, Heart Failure, CKD stage>3, Dementia etc etc..) . and from a report I just read the length of stay averaged at 21 days or with death Length of stay is 14 days..
As I said -- I hope this wonder drug does work...
But HOW DO YOU RUN A TEST OVER 28 TWENTY EIGHT DAYS when the hospitalisation periods is less then average case.
To find over 250 patients or test samples for the 28day tests --- would continue to provide an Incomplete or Inconclusive Result.
Looks great on paper and will surely bolster the share price short term --- But is it plausable?
- Forums
- ASX - By Stock
- RGT
- Ann: 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL
Ann: 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL, page-5
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.01M |
Open | High | Low | Value | Volume |
29.5¢ | 29.5¢ | 29.5¢ | $559 | 1.895K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1643 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 50 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1643 | 0.295 |
1 | 6000 | 0.255 |
2 | 4408 | 0.250 |
1 | 20000 | 0.245 |
1 | 2200 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 50 | 1 |
0.305 | 2073 | 2 |
0.310 | 50 | 1 |
0.320 | 50 | 1 |
0.360 | 2500 | 1 |
Last trade - 12.51pm 13/11/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online